Advertisement
New Zealand markets close in 2 hours 4 minutes

  • NZX 50

    11,853.62
    -92.81 (-0.78%)
     

  • NZD/USD

    0.5963
    +0.0014 (+0.23%)
     

  • NZD/EUR

    0.5555
    +0.0015 (+0.27%)
     

  • ALL ORDS

    7,856.60
    -80.90 (-1.02%)
     

  • ASX 200

    7,595.60
    -87.40 (-1.14%)
     

  • OIL

    83.76
    +0.19 (+0.23%)
     

  • GOLD

    2,344.10
    +1.60 (+0.07%)
     

  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     

  • DAX

    17,917.28
    -171.42 (-0.95%)
     

  • Hang Seng

    17,563.82
    +279.28 (+1.62%)
     

  • NIKKEI 225

    37,780.35
    +151.87 (+0.40%)
     

  • NZD/JPY

    92.7190
    +0.2230 (+0.24%)
     

Worldwide Skin Graft Industry to 2028 - 3D-printed Skin Grafts Presents Opportunities

Research and Markets
·8-min read

Dublin, Dec. 09, 2021 (GLOBE NEWSWIRE) -- The "Skin Graft Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Graft Thickness, Application, Equipment, and End User and Geography" report has been added to ResearchAndMarkets.com's offering.

The skin graft market was valued at US$ 985.4 million in 2020 and is projected to reach US$ 1,673.5 million by 2028; it is expected to grow at a CAGR of 6.84% from 2020 to 2028.

The key factors such as the increasing numbers of burn injuries and rising prevalence of skin cancer and diabetes drive the growth of the skin graft market. However, the high cost of skin grafting procedures and alternatives for skin grafts hinder the market growth.

Skin grafting is a surgery involving the transplantation of skin using various types of skin graft. Skin grafts are also used to treat extensive wounding or trauma and burns. In skin grafting procedure, a small patch of the skin is removed from a patient's body part and attached to or transplanted to the affected area of the body.

The increasing number of burn injuries has pushed healthcare systems to implement burn care programs and management services. For instance, Saudi Arabia has implemented a burn care program under which 17 burn care facilities are distributed across the country. The organizations in the country are actively enforcing burn care treatment to enhance skin grafting. For instance, the Burn Unit and Plastic Surgery Department of Prince Sultan Military Medical City's (PSMMC) burn care services have included a skin grafting program and long-term rehabilitation. Thus, the increasing number of injuries has contributed significantly to the growing demand for skin graft treatments, which is expected to continue during the forecast period leveraging the market's growth.

Based on product, the skin graft market is segmented into autologous, allogeneic, xenogeneic, prosthetic, and isogeneic. In 2020, the autologous segment accounted for the largest share in the market owing to the wide use of autologous grafts for treating burns and wounds.

In terms of application, the skin graft market is segmented into burns, extensive wound, skin cancer, and other applications. The burns segment held the largest share of the market in 2020, and it is estimated to register the highest CAGR in the market during the forecast period.

Key Topics Covered:

1. Introduction

2. Skin Graft Market - Key Takeaways

3. Research Methodology

4. Skin Graft Market- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Expert Opinion

5. Skin Graft Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Number of Burn Injuries
5.1.2 Rising Prevalence of Skin Cancer and Diabetes
5.2 Market Restraints
5.2.1 High Cost of Skin Grafting Procedures
5.2.2 Alternatives for Skin Grafts
5.3 Market Opportunities
5.3.1 3D-printed Skin Grafts
5.4 Future Trends
5.4.1 Research Activities and Product Innovations
5.5 Impact Analysis

6. Skin Graft Market - Global Analysis
6.1 Global Skin graft Market Revenue Forecast and Analysis
6.2 Global Skin Graft Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. Skin Graft Market Analysis - By Product
7.1 Overview
7.2 Skin Graft Market Revenue Share, by Product (2020 and 2028)
7.3 Autologous
7.3.1 Overview
7.3.2 Autologous: Skin Graft Market- Revenue and Forecast to 2028 (US$ Million)
7.4 Allogeneic
7.4.1 Overview
7.4.2 Allogeneic: Skin Graft Market- Revenue and Forecast to 2028 (US$ Million)
7.5 Xenogeneic
7.5.1 Overview
7.5.2 Xenogeneic: Skin Graft Market- Revenue and Forecast to 2028 (US$ Million)
7.6 Prosthetic
7.6.1 Overview
7.6.2 Prosthetic: Skin Graft Market- Revenue and Forecast to 2028 (US$ Million)
7.7 Isogeneic Grafts
7.7.1 Overview
7.7.2 Isogeneic Grafts: Skin Graft Market- Revenue and Forecast to 2028 (US$ Million)

8. Skin Graft Market Analysis - By Graft Thickness
8.1 Overview
8.2 Skin Graft Market Revenue Share, by Graft Thickness (2020 and 2028)
8.3 Split Thickness
8.3.1 Overview
8.3.2 Split Thickness: Skin Graft Market- Revenue and Forecast to 2028 (US$ Million)
8.4 Full-Thickness Skin Grafts
8.4.1 Overview
8.4.2 Full-Thickness Skin Grafts: Skin Graft Market- Revenue and Forecast to 2028 (US$ Million)
8.5 Composite Graft
8.5.1 Overview
8.5.2 Composite Graft: Skin Graft Market- Revenue and Forecast to 2028 (US$ Million)

9. Skin Graft Market Analysis - By Equipment
9.1 Overview
9.2 Skin Graft Market Revenue Share, by Equipment (2020 and 2028)
9.3 Dermatome
9.3.1 Overview
9.3.2 Dermatome: Skin Graft Market- Revenue and Forecast to 2028 (US$ Million)
9.4 General Surgical Instruments
9.4.1 Overview
9.4.2 General Surgical Instruments: Skin Graft Market- Revenue and Forecast to 2028 (US$ Million)
9.5 Consumables
9.5.1 Overview
9.5.2 Consumables: Skin Graft Market- Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Skin Graft Market- Revenue and Forecast to 2028 (US$ Million)

10. Skin Graft Market Analysis - By Application
10.1 Overview
10.2 Skin Graft Market Revenue Share, by Application (2020 and 2028)
10.3 Burns
10.3.1 Overview
10.3.2 Burns: Skin Graft Market- Revenue and Forecast to 2028 (US$ Million)
10.4 Extensive Wound
10.4.1 Overview
10.4.2 Extensive Wound: Skin Graft Market- Revenue and Forecast to 2028 (US$ Million)
10.5 Skin Cancer
10.5.1 Overview
10.5.2 Skin Cancer: Skin Graft Market- Revenue and Forecast to 2028 (US$ Million)
10.6 Other Applications
10.6.1 Overview
10.6.2 Other Applications: Skin Graft Market- Revenue and Forecast to 2028 (US$ Million)

11. Skin Graft Market- By End User
11.1 Overview
11.2 Skin Graft Market Revenue Share, by End User (2020 and 2028)
11.3 Hospitals
11.3.1 Overview
11.3.2 Hospitals: Skin Graft Market- Revenue and Forecast to 2028 (US$ Million)
11.4 Ambulatory Surgical Centers
11.4.1 Overview
11.4.2 Ambulatory Surgical Centers: Skin Graft Market- Revenue and Forecast to 2028 (US$ Million)
11.5 Dermatology Clinics
11.5.1 Overview
11.5.2 Dermatology Clinics: Skin Graft Market- Revenue and Forecast to 2028 (US$ Million)

12. Skin Graft Market - Geographical Analysis

13. Impact of COVID-19 Pandemic on Global Skin graft Market
13.1 North America: Impact Assessment of COVID-19 Pandemic
13.2 Europe: Impact Assessment of COVID-19 Pandemic
13.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
13.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
13.5 South & Central America: Impact Assessment of COVID-19 Pandemic

14. Skin Graft Market- Industry Landscape
14.1 Overview
14.2 Growth Strategies Done by the Companies in the Market, (%)
14.3 Organic Developments
14.3.1 Overview
14.4 Inorganic Developments
14.4.1 Overview

15. Company Profiles
15.1 B. Braun Melsungen AG
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Integra Life Sciences Corporation
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Smith & Nephew
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 AVITA Medical
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 MiMedx
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Organogenesis Inc.
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Tissue Regenix Group
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Zimmer Biomet
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 De Soutter Medical
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Nouvag AG
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments

16. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/j5hoov

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900